Borraginol-N

Borraginol-N

Manufacturer:

Takeda
Full Prescribing Info
Contents
Lithospermi radix extract, ethyl aminobenzoate, dibucaine HCl, diphenhydramine HCl, cetrimide.
Description
Each gram of rectal ointment and each suppository contains Lithospermi radix extract 0.09 and 0.18 mg, ethyl aminobenzoate 10 and 20 mg, dibucaine HCl 0.25 and 0.5 mg, diphenhydramine HCl 0.25 and 0.5 mg and cetrimide 1.25 and 2.5 mg, respectively.
Action
Antihemorrhoidal.
It alleviates inflammation, itching, edema, pain and allergic symptoms, and promotes healing.
Borraginol-N has prompt antiphlogistic, analgesic, antiseptic, antipruritic and hemostatic actions on hemorrhoids, hemorrhoidal bleeding, wounds and burns, and accelerates the formation of granulation and epithelium of ulcerated wounds.
Indications/Uses
Internal and external hemorrhoids, lacerated anal wounds, anal prolapse, periproctitis, hemorrhoidal bleeding and anal pruritus.
Dosage/Direction for Use
Ointment: Spread 2-5 g on a piece of gauze or lint sheet and apply to the afflicted areas. Change the gauze or lint sheet 2-3 times daily.
Children: Borraginol-N ointment may be applied by rubbing-in.
Suppository: Remove wrapper and insert 1 suppository intrarectally, 3 times daily (morning, afternoon and evening). In severe cases, also use another suppository before retiring.
Storage
Ointment: Store at room temperature.
Suppository: Store in a cool place.
ATC Classification
C05AD03 - benzocaine ; Belongs to the class of local anesthetics. Used in the topical treatment of hemorrhoids and anal fissures.
Presentation/Packing
Rectal oint 15 g x 1's. Rectal supp 10's.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in